In this study, we investigated the integration of Human Herpesvirus 8 (HHV-8) into the human genome using the primary effusion lymphoma (PEL) cell line BC-3. Through next-generation sequencing (NGS) ...

Autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, celiac disease, and other autoimmune disorders, may increase the risk for NHLs like DLBCL. When the ...

Primary effusion lymphoma (PEL) is an incurable non-Hodgkin’s lymphoma and novel biology-based treatments are urgently needed in clinical settings. Shikonin (SHK), a napthoquinone derivative, has been ...

Primary effusion lymphoma (PEL) is an aggressive B-cell lymphoma confined to body cavities and universally associated with human herpesvirus type 8 infection. The prognosis of this entity remains poor ...

A 59-year-old Caucasian man infected with HIV, in remission from human herpes virus-8-positive extracavitary primary effusion lymphoma (EC-PEL), presented to a sexual health clinic with fever and ...

B cell-derived non-Hodgkin lymphomas (NHLs) consist of a very diverse set of malignancies. One NHL subtype, primary effusion lymphoma (PEL), has a poor prognosis with patients having a median survival ...

The researchers reported in the journal Proceedings of the National Academy of Sciences they identified a novel therapeutic target for primary effusion lymphoma, a type of non-Hodgkin lymphoma ...

Primary effusion lymphoma (PEL) is defined as a rare subtype of non-Hodgkin's B-cell lymphoma which is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) in immunosuppressed patients. PEL is an ...